November 15, 2013
Athersys (ATHX) Q3/13 Results – HOLD
November 12, 2013
Mesoblast ADR (USOTC: MBLTY) MPCs induce functional recovery in Ischemic Stroke model - HOLD
November 6, 2013
Futures are UP, HIGHER open; STEM reports with “cap ass ity”
November 5, 2013
UC San Diego Plans to open Stem Cell Center
October 31, 2013
Aastrom (ASTM) Regains NASDAQ Compliance - SELL
October 31, 2013
Selling and Short Ratios
October 29, 2013
Stemline (STML) $3 M Collaboration for SL-401
October 25, 2013
Blowin' in the Wind
October 24, 2013
Finding the clues to the future, check the past
October 24, 2013
Riding the sentiment trail with the “usual suspects”
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.